PowerShow.com
  • Help
  • Preferences
  • Sign up
  • Log in
Advanced
Free template

Anthracycline PowerPoint PPT Presentations

Grid List
All Time
All TimeAdded TodayAdded This WeekAdded This Month
Show:
Recommended
RecommendedRelevanceLatestHighest RatedMost Viewed
Sort by:
Featured Presentations
Search Results
Table 3 Adjuvant anthracycline criteria based upon anthracycline  PowerPoint PPT Presentation
Table 3 Adjuvant anthracycline criteria based upon anthracycline - Table 3 Adjuvant anthracycline criteria based upon anthracycline strength' Bedard, P. L. et al. (2009) Taxanes: optimizing adjuvant chemotherapy for early ...
Table 3 Adjuvant anthracycline criteria based upon anthracycline strength' Bedard, P. L. et al. (2009) Taxanes: optimizing adjuvant chemotherapy for early ...
| PowerPoint PPT presentation | free to download
Anthracyclines PowerPoint PPT Presentation
Anthracyclines - Streptomyces bacteria. Basic Terms and Definitions. Chemotherapy: Cancer treatment that uses medicine to destroy cancer cells. Can be used alone or in combination ...
Streptomyces bacteria. Basic Terms and Definitions. Chemotherapy: Cancer treatment that uses medicine to destroy cancer cells. Can be used alone or in combination ...
| PowerPoint PPT presentation | free to download
Bortezomib   Anthracyclines PowerPoint PPT Presentation
Bortezomib Anthracyclines - Title: Velcade Peer to Peer MM Author: CK Gutheil Last modified by: Owner Created Date: 3/7/2000 9:53:33 PM Document presentation format:
Title: Velcade Peer to Peer MM Author: CK Gutheil Last modified by: Owner Created Date: 3/7/2000 9:53:33 PM Document presentation format:
| PowerPoint PPT presentation | free to view
Anthracycline induced Cardiomyopathy PowerPoint PPT Presentation
Anthracycline induced Cardiomyopathy - Title: Anthracycline induced Cardiomyopathy Author: Domenick Roma Last modified by: DOM Created Date: 12/9/2009 11:23:08 PM Document presentation format
Title: Anthracycline induced Cardiomyopathy Author: Domenick Roma Last modified by: DOM Created Date: 12/9/2009 11:23:08 PM Document presentation format
| PowerPoint PPT presentation | free to view
Prevention and therapy of anthracycline cardiotoxicity Prevenzione e terapia della tossicit PowerPoint PPT Presentation
Prevention and therapy of anthracycline cardiotoxicity Prevenzione e terapia della tossicit - Prevention and therapy of anthracycline cardiotoxicity Prevenzione e terapia della tossicit cardiaca da antracicline Dott. Marzia Lotrionte Universit Cattolica ...
Prevention and therapy of anthracycline cardiotoxicity Prevenzione e terapia della tossicit cardiaca da antracicline Dott. Marzia Lotrionte Universit Cattolica ...
| PowerPoint PPT presentation | free to download
Carvedilol Prophylaxis in Anthracycline-Induced Cardiomyopathy PowerPoint PPT Presentation
Carvedilol Prophylaxis in Anthracycline-Induced Cardiomyopathy - ... Light micrograph of normal cardiac myocyte ... start of CT 25 patients received placebo Duration 6 months during CT Primary end point Systolic function RCT: ...
... Light micrograph of normal cardiac myocyte ... start of CT 25 patients received placebo Duration 6 months during CT Primary end point Systolic function RCT: ...
| PowerPoint PPT presentation | free to view
Detecting Anthracycline Induced Intrachromosomal Recombination in Saccharomyces cerevisiae Using a D PowerPoint PPT Presentation
Detecting Anthracycline Induced Intrachromosomal Recombination in Saccharomyces cerevisiae Using a D - Alexis Snow. Alpha Chi. Dr William Mackay. Edinboro ... 2000 Texas J. ... LA, Cauchi, AA, and Weaver LT; Texas Journal of Science 52 (3): 223-229 ...
Alexis Snow. Alpha Chi. Dr William Mackay. Edinboro ... 2000 Texas J. ... LA, Cauchi, AA, and Weaver LT; Texas Journal of Science 52 (3): 223-229 ...
| PowerPoint PPT presentation | free to view
A Phase III Study (EMBRACE) of Eribulin Mesylate versus Treatment of Physician's Choice in Patients with Locally Recurrent or Metastatic Breast Cancer Previously Treated with an Anthracycline and a Taxane PowerPoint PPT Presentation
A Phase III Study (EMBRACE) of Eribulin Mesylate versus Treatment of Physician's Choice in Patients with Locally Recurrent or Metastatic Breast Cancer Previously Treated with an Anthracycline and a Taxane - Title: Main Title Slide Always use Title Case on Slide Titles Author: Fernando G Rendina Last modified by: Deepti Bhatia User Created Date: 7/15/2010 1:59:55 PM
Title: Main Title Slide Always use Title Case on Slide Titles Author: Fernando G Rendina Last modified by: Deepti Bhatia User Created Date: 7/15/2010 1:59:55 PM
| PowerPoint PPT presentation | free to download
Different dosage schedules for reducing cardiotoxicity in cancer patients receiving anthracycline ch PowerPoint PPT Presentation
Different dosage schedules for reducing cardiotoxicity in cancer patients receiving anthracycline ch - Hortobagyi1989 52 adult mamma epi. median 520. Lipshultz 2002 145 child leukemia doxo ... median 360. Zalupski 1991 240 adult mamma doxo. median 240 ...
Hortobagyi1989 52 adult mamma epi. median 520. Lipshultz 2002 145 child leukemia doxo ... median 360. Zalupski 1991 240 adult mamma doxo. median 240 ...
| PowerPoint PPT presentation | free to view
The Effect on pCR of Bevacizumab and/or Antimetabolites Added to Standard Neoadjuvant Chemotherapy: NSABP Protocol B-401  Neoadjuvant Bevacizumab and Anthracycline PowerPoint PPT Presentation
The Effect on pCR of Bevacizumab and/or Antimetabolites Added to Standard Neoadjuvant Chemotherapy: NSABP Protocol B-401 Neoadjuvant Bevacizumab and Anthracycline - Neoadjuvant Bevacizumab and Anthracycline Taxane-Based Chemotherapy in 684 Triple-Negative Primary Breast Cancers: Secondary Endpoint Analysis of
Neoadjuvant Bevacizumab and Anthracycline Taxane-Based Chemotherapy in 684 Triple-Negative Primary Breast Cancers: Secondary Endpoint Analysis of
| PowerPoint PPT presentation | free to download
Lapatinib versus Trastuzumab in Combination with Neoadjuvant Anthracycline-Taxane-Based Chemotherapy: Primary Efficacy Endpoint Analysis of the GEPARQUINTO Study (GBG 44) PowerPoint PPT Presentation
Lapatinib versus Trastuzumab in Combination with Neoadjuvant Anthracycline-Taxane-Based Chemotherapy: Primary Efficacy Endpoint Analysis of the GEPARQUINTO Study (GBG 44) - Title: Research To Practice Author: Fernando G Rendina Last modified by: Fernando Rendina Created Date: 5/20/2009 1:19:04 AM Document presentation format
Title: Research To Practice Author: Fernando G Rendina Last modified by: Fernando Rendina Created Date: 5/20/2009 1:19:04 AM Document presentation format
| PowerPoint PPT presentation | free to download
Integration of Capecitabine into Anthracycline- and Taxane-Based Adjuvant Therapy for Triple Negative Early Breast Cancer: Final Subgroup Analysis of the FinXX Study1 Review of Capecitabine for the Treatment of Triple-Negative Early Breast Cancer2 PowerPoint PPT Presentation
Integration of Capecitabine into Anthracycline- and Taxane-Based Adjuvant Therapy for Triple Negative Early Breast Cancer: Final Subgroup Analysis of the FinXX Study1 Review of Capecitabine for the Treatment of Triple-Negative Early Breast Cancer2 - Integration of Capecitabine into Anthracycline- and Taxane-Based Adjuvant Therapy for Triple Negative Early Breast Cancer: Final Subgroup Analysis of the FinXX Study1
Integration of Capecitabine into Anthracycline- and Taxane-Based Adjuvant Therapy for Triple Negative Early Breast Cancer: Final Subgroup Analysis of the FinXX Study1
| PowerPoint PPT presentation | free to download
Album photo PowerPoint PPT Presentation
Album photo - cancers du sein progres des connaissances retrospective 2005 2009 bases historiques duree et effet dose - 4 a 6 cycles avec anthracyclines (st gallen 2003) - 6 ...
cancers du sein progres des connaissances retrospective 2005 2009 bases historiques duree et effet dose - 4 a 6 cycles avec anthracyclines (st gallen 2003) - 6 ...
| PowerPoint PPT presentation | free to download
Herceptin PowerPoint PPT Presentation
Herceptin - Herceptin (trastuzumab) in combination with chemotherapy: pivotal metastatic breast cancer survival data No prior anthracyclines n=281 Summary of HO648g trial ...
Herceptin (trastuzumab) in combination with chemotherapy: pivotal metastatic breast cancer survival data No prior anthracyclines n=281 Summary of HO648g trial ...
| PowerPoint PPT presentation | free to download
La chemioterapia adiuvante PowerPoint PPT Presentation
La chemioterapia adiuvante - La chemioterapia adiuvante Lucia Del Mastro Istituto Naz. per la Ricerca sul Cancro - Genova Roma 18 Febbraio 2005 Adjuvant chemotherapy The present Anthracyclines ...
La chemioterapia adiuvante Lucia Del Mastro Istituto Naz. per la Ricerca sul Cancro - Genova Roma 18 Febbraio 2005 Adjuvant chemotherapy The present Anthracyclines ...
| PowerPoint PPT presentation | free to view
Taxanes PowerPoint PPT Presentation
Taxanes - Taxanes Taxanes are among the most active agents for metastatic breast cancer Docetaxel, Paclitaxel, NabPaclitaxel. Anthracyclines Doxorubicin, Epirubicin ...
Taxanes Taxanes are among the most active agents for metastatic breast cancer Docetaxel, Paclitaxel, NabPaclitaxel. Anthracyclines Doxorubicin, Epirubicin ...
| PowerPoint PPT presentation | free to view
Aprepitant: A new Drug for Chemotherapy Induced Nausea and Vomiting PowerPoint PPT Presentation
Aprepitant: A new Drug for Chemotherapy Induced Nausea and Vomiting - Uncontrolled emesis affect quality of life and impair compliance with treatment ... Effective in Breast cancer patients (cyclophosphamide/anthracycline based ...
Uncontrolled emesis affect quality of life and impair compliance with treatment ... Effective in Breast cancer patients (cyclophosphamide/anthracycline based ...
| PowerPoint PPT presentation | free to download
Treatment Options for Women with HER2 Positive Breast Cancer PowerPoint PPT Presentation
Treatment Options for Women with HER2 Positive Breast Cancer - pathophysiology of HER-2 family of proteins. diagnostic testing ... Paclitaxel for patients who had received adjuvant anthracycline. R. A. N. D. O. M. I. Z. E ...
pathophysiology of HER-2 family of proteins. diagnostic testing ... Paclitaxel for patients who had received adjuvant anthracycline. R. A. N. D. O. M. I. Z. E ...
| PowerPoint PPT presentation | free to view
Xeloda monotherapy: origin of a species PowerPoint PPT Presentation
Xeloda monotherapy: origin of a species - 1970 1980s: anthracyclines most. active agents for MBC ... Taxane-pretreated: only Xeloda achieves consistently good efficacy with overall ...
1970 1980s: anthracyclines most. active agents for MBC ... Taxane-pretreated: only Xeloda achieves consistently good efficacy with overall ...
| PowerPoint PPT presentation | free to view
Updates from the San Antonio Breast Cancer Symposium 2007: Medical Oncology PowerPoint PPT Presentation
Updates from the San Antonio Breast Cancer Symposium 2007: Medical Oncology - ... from the San Antonio Breast Cancer Symposium 2007: Medical Oncology. Hope S. Rugo, MD ... Ongoing US oncology trial is evaluating the role of anthracyclines: ...
... from the San Antonio Breast Cancer Symposium 2007: Medical Oncology. Hope S. Rugo, MD ... Ongoing US oncology trial is evaluating the role of anthracyclines: ...
| PowerPoint PPT presentation | free to download
Daunomycin Pharmacokinetics in Children PowerPoint PPT Presentation
Daunomycin Pharmacokinetics in Children - ... Pharmacokinetics in Children. Stacey Berg, MD. Anthracyclines widely used in pediatric cancer ... Anticancer drug dosing in children based on body size ...
... Pharmacokinetics in Children. Stacey Berg, MD. Anthracyclines widely used in pediatric cancer ... Anticancer drug dosing in children based on body size ...
| PowerPoint PPT presentation | free to view
Complications of Chemotherapy PowerPoint PPT Presentation
Complications of Chemotherapy - Treatment with drugs that kill cancer cells (or make them ... Palliative chemotherapy. Categories of Chemotherapy. Antibiotic derived anthracyclines, bleomycin ...
Treatment with drugs that kill cancer cells (or make them ... Palliative chemotherapy. Categories of Chemotherapy. Antibiotic derived anthracyclines, bleomycin ...
| PowerPoint PPT presentation | free to view
Capecitabine/Docetaxel (XT): Superior Response Rate and TTP PowerPoint PPT Presentation
Capecitabine/Docetaxel (XT): Superior Response Rate and TTP - Time (months) Source: O'Shaughnessy J et al. Superior survival with capecitabine plus ... therapy in anthracycline-pretreated patients with advanced breast ...
Time (months) Source: O'Shaughnessy J et al. Superior survival with capecitabine plus ... therapy in anthracycline-pretreated patients with advanced breast ...
| PowerPoint PPT presentation | free to download
Targeted therapies nella pratica clinica delle neoplasie solide: Neoplasie della mammella PowerPoint PPT Presentation
Targeted therapies nella pratica clinica delle neoplasie solide: Neoplasie della mammella - ... Triple ... Anthracyclines in Metastatic Breast Cancer. Increased ORR, TTP, OS ... positive, or high-risk LN-negative, HER2-positive early breast cancer ...
... Triple ... Anthracyclines in Metastatic Breast Cancer. Increased ORR, TTP, OS ... positive, or high-risk LN-negative, HER2-positive early breast cancer ...
| PowerPoint PPT presentation | free to view
Paziente in et fertile PowerPoint PPT Presentation
Paziente in et fertile - ... yrs after adjuvant anthracycline and taxane ... with adjuvant DOX CTX (AC) followed ... Gn-RH A added to adjuvant CT protect ovarian. function in young women ...
... yrs after adjuvant anthracycline and taxane ... with adjuvant DOX CTX (AC) followed ... Gn-RH A added to adjuvant CT protect ovarian. function in young women ...
| PowerPoint PPT presentation | free to view
Bez nadpisu PowerPoint PPT Presentation
Bez nadpisu - withdrawal symptoms following discontinuation of treatment with benzodiazepines, ... the development of anthracycline-induced congestive heart failure is mainly due ...
withdrawal symptoms following discontinuation of treatment with benzodiazepines, ... the development of anthracycline-induced congestive heart failure is mainly due ...
| PowerPoint PPT presentation | free to download
Inhibiteurs de topoisom PowerPoint PPT Presentation
Inhibiteurs de topoisom - Title: Inhibiteurs de topoisom rases Author: Marty Last modified by: MODO Created Date: 11/13/2005 9:52:22 PM Document presentation format: Affichage l' cran
Title: Inhibiteurs de topoisom rases Author: Marty Last modified by: MODO Created Date: 11/13/2005 9:52:22 PM Document presentation format: Affichage l' cran
| PowerPoint PPT presentation | free to download
Julie R. Gralow, M.D. PowerPoint PPT Presentation
Julie R. Gralow, M.D. - Long-term Follow-up of Breast Cancer Patients Julie R. Gralow, M.D. Director, Breast Medical Oncology, Seattle Cancer Care Alliance Professor, Medical Oncology ...
Long-term Follow-up of Breast Cancer Patients Julie R. Gralow, M.D. Director, Breast Medical Oncology, Seattle Cancer Care Alliance Professor, Medical Oncology ...
| PowerPoint PPT presentation | free to download
Cardiotoxic Medications PowerPoint PPT Presentation
Cardiotoxic Medications - Title: Slide 1 Author: CareGroup I.S. Last modified by: WMANNING Created Date: 12/29/2007 8:34:19 PM Document presentation format: On-screen Show Company
Title: Slide 1 Author: CareGroup I.S. Last modified by: WMANNING Created Date: 12/29/2007 8:34:19 PM Document presentation format: On-screen Show Company
| PowerPoint PPT presentation | free to view
Liposomes: PowerPoint PPT Presentation
Liposomes: - Title: PowerPoint Presentation Last modified by: APTE Created Date: 1/1/1601 12:00:00 AM Document presentation format: On-screen Show Other titles
Title: PowerPoint Presentation Last modified by: APTE Created Date: 1/1/1601 12:00:00 AM Document presentation format: On-screen Show Other titles
| PowerPoint PPT presentation | free to download
Topoisomerase-II?  a Predictive Molecular Marker in Breast Cancer: PowerPoint PPT Presentation
Topoisomerase-II? a Predictive Molecular Marker in Breast Cancer: - Pauletti G, Dandekar U, Morisson J. Ramos L. He-Jing Wang, Seelig S, and Slamon DJ ... Most studies are small and underpowered. Many investigators use IHC ...
Pauletti G, Dandekar U, Morisson J. Ramos L. He-Jing Wang, Seelig S, and Slamon DJ ... Most studies are small and underpowered. Many investigators use IHC ...
| PowerPoint PPT presentation | free to download
Scompenso Cardiaco: Corso teorico-pratico di formazione generale  Scompenso Cardiaco da chemioterapici PowerPoint PPT Presentation
Scompenso Cardiaco: Corso teorico-pratico di formazione generale Scompenso Cardiaco da chemioterapici - Scompenso Cardiaco: Corso teorico-pratico di formazione generale Scompenso Cardiaco da chemioterapici Dott. Marzia Lotrionte Unit per lo Scompenso Cardiaco e la ...
Scompenso Cardiaco: Corso teorico-pratico di formazione generale Scompenso Cardiaco da chemioterapici Dott. Marzia Lotrionte Unit per lo Scompenso Cardiaco e la ...
| PowerPoint PPT presentation | free to download
REFERENTIELS GYNECOLOGIE PowerPoint PPT Presentation
REFERENTIELS GYNECOLOGIE - REFERENTIELS GYNECOLOGIE CANCER DU SEIN PRINCIPE DES TABLEAUX D finition de l agressivit du cancer du sein m tastatique: consensus d expert GROUPE DE RISQUE ...
REFERENTIELS GYNECOLOGIE CANCER DU SEIN PRINCIPE DES TABLEAUX D finition de l agressivit du cancer du sein m tastatique: consensus d expert GROUPE DE RISQUE ...
| PowerPoint PPT presentation | free to download
Analyze Future: Ovarian Cancer Treatment Drugs Markets in China PowerPoint PPT Presentation
Analyze Future: Ovarian Cancer Treatment Drugs Markets in China - Analyze Future: Ovarian Cancer Treatment Drugs Markets in China To Get More Details @ http://www.analyzefuture.com/ovarian-cancer-treatment-drugs-in-china-market China's demand for Ovarian Cancer Treatment Drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2003, 2008 and 2013) and long-term forecasts through 2018 and 2023 are presented. Major producers in China are profiled.
Analyze Future: Ovarian Cancer Treatment Drugs Markets in China To Get More Details @ http://www.analyzefuture.com/ovarian-cancer-treatment-drugs-in-china-market China's demand for Ovarian Cancer Treatment Drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2003, 2008 and 2013) and long-term forecasts through 2018 and 2023 are presented. Major producers in China are profiled.
| PowerPoint PPT presentation | free to download
Subtitle 2 PowerPoint PPT Presentation
Subtitle 2 - What is Cardiac Toxicity? Damage to the heart muscle by a toxin is called cardiac toxicity. They may ... Discomfort lying in supine. Swelling of the ankles. 10 ...
What is Cardiac Toxicity? Damage to the heart muscle by a toxin is called cardiac toxicity. They may ... Discomfort lying in supine. Swelling of the ankles. 10 ...
| PowerPoint PPT presentation | free to download
BREAST CANCER PowerPoint PPT Presentation
BREAST CANCER - breast cancer b.klein oncology meir hospital
breast cancer b.klein oncology meir hospital
| PowerPoint PPT presentation | free to download
TRAITEMENT DU LNH DU MANTEAU PowerPoint PPT Presentation
TRAITEMENT DU LNH DU MANTEAU - ... Zinzani 2000 P DFS RC % RG % N Seulement 3 tudes randomis es ont t publi es Recul Insuffisant 48 m 24m 48m 24m Survie 0,003 0,08 IPI faible ...
... Zinzani 2000 P DFS RC % RG % N Seulement 3 tudes randomis es ont t publi es Recul Insuffisant 48 m 24m 48m 24m Survie 0,003 0,08 IPI faible ...
| PowerPoint PPT presentation | free to view
Strategia terapeutica nella malattia avanzata PowerPoint PPT Presentation
Strategia terapeutica nella malattia avanzata - ... % 182 vs 189 453 vs 454 340 vs 328 170 vs 182 Patients, No. Exemestane Letrozole Anastrozole Anastrozole Nabholtz et al. J Clin Oncol 18:3758, 2000; ...
... % 182 vs 189 453 vs 454 340 vs 328 170 vs 182 Patients, No. Exemestane Letrozole Anastrozole Anastrozole Nabholtz et al. J Clin Oncol 18:3758, 2000; ...
| PowerPoint PPT presentation | free to view
ADR of Cancer Chemotherapy PowerPoint PPT Presentation
ADR of Cancer Chemotherapy - Title: 1 Author: use Last modified by: Created Date: 11/21/2007 2:08:39 AM Document presentation format: (4:3) Company
Title: 1 Author: use Last modified by: Created Date: 11/21/2007 2:08:39 AM Document presentation format: (4:3) Company
| PowerPoint PPT presentation | free to download
BIOMARKERS. Roberto Bordonaro Struttura Complessa di Oncologia Medica ARNAS Garibaldi Catania PowerPoint PPT Presentation
BIOMARKERS. Roberto Bordonaro Struttura Complessa di Oncologia Medica ARNAS Garibaldi Catania - BIOMARKERS. Roberto Bordonaro Struttura Complessa di Oncologia Medica ARNAS Garibaldi Catania R. Danesi Il ruolo dell'angiogenesi * Clinical trials assessing in-situ ...
BIOMARKERS. Roberto Bordonaro Struttura Complessa di Oncologia Medica ARNAS Garibaldi Catania R. Danesi Il ruolo dell'angiogenesi * Clinical trials assessing in-situ ...
| PowerPoint PPT presentation | free to download
Anticancer Agents PowerPoint PPT Presentation
Anticancer Agents - Anticancer Agents By: Cristina Sanders * * * * * * * * * * * * * * * * * * * * What is cancer? Cancer is a group of diseases that are characterized by the loss of ...
Anticancer Agents By: Cristina Sanders * * * * * * * * * * * * * * * * * * * * What is cancer? Cancer is a group of diseases that are characterized by the loss of ...
| PowerPoint PPT presentation | free to download
La chemioterapia adiuvante PowerPoint PPT Presentation
La chemioterapia adiuvante - Recommended Adjuvant Chemotherapy Regimens. Standard efficacy ... Adjuvant: High Risk Node Negative ... Taxanes as adjuvant therapy: conclusions. Paclitaxel ...
Recommended Adjuvant Chemotherapy Regimens. Standard efficacy ... Adjuvant: High Risk Node Negative ... Taxanes as adjuvant therapy: conclusions. Paclitaxel ...
| PowerPoint PPT presentation | free to view
Cancer Incidence and Mortality PowerPoint PPT Presentation
Cancer Incidence and Mortality - Cancer Incidence and Mortality Cancer is a common disease. One in three people in the Western World contract cancer and one in four die from it.
Cancer Incidence and Mortality Cancer is a common disease. One in three people in the Western World contract cancer and one in four die from it.
| PowerPoint PPT presentation | free to download
Extravasation: new strategies PowerPoint PPT Presentation
Extravasation: new strategies - Potential of damage of cytotoxic agents Predisposition und risk factors Prevention Early detection integrating ... Vesicant potential of effective drugs and/or ...
Potential of damage of cytotoxic agents Predisposition und risk factors Prevention Early detection integrating ... Vesicant potential of effective drugs and/or ...
| PowerPoint PPT presentation | free to view
David Malka, MD, PhD Head of Gastrointestinal Tumor Group Department of Oncologic Medicine Institut Gustave Roussy Villejuif, France PowerPoint PPT Presentation
David Malka, MD, PhD Head of Gastrointestinal Tumor Group Department of Oncologic Medicine Institut Gustave Roussy Villejuif, France - Treatment of Advanced HER2-Negative Gastroesophageal Carcinomas David Malka, MD, PhD Head of Gastrointestinal Tumor Group Department of Oncologic Medicine
Treatment of Advanced HER2-Negative Gastroesophageal Carcinomas David Malka, MD, PhD Head of Gastrointestinal Tumor Group Department of Oncologic Medicine
| PowerPoint PPT presentation | free to download
TAXOL paclitaxel for Adjuvant Treatment of Node Positive Breast Cancer Oncologic Drug Advisory Commi PowerPoint PPT Presentation
TAXOL paclitaxel for Adjuvant Treatment of Node Positive Breast Cancer Oncologic Drug Advisory Commi - TAXOL (paclitaxel) for Adjuvant Treatment of Node Positive Breast Cancer ... Adjuvant Chemotherapy of Breast Cancer. Larry Norton, M.D. ...
TAXOL (paclitaxel) for Adjuvant Treatment of Node Positive Breast Cancer ... Adjuvant Chemotherapy of Breast Cancer. Larry Norton, M.D. ...
| PowerPoint PPT presentation | free to view
Strategia terapeutica nella malattia avanzata PowerPoint PPT Presentation
Strategia terapeutica nella malattia avanzata - Taylor, JCO 1998. Randomized trials of OA vs Tamoxifen. No diff. No diff. No diff. OA (surg) ... Boccardo, Ann Oncol 94. Jonat, EJC 95. Klijn, JNCI 00. Outcome ...
Taylor, JCO 1998. Randomized trials of OA vs Tamoxifen. No diff. No diff. No diff. OA (surg) ... Boccardo, Ann Oncol 94. Jonat, EJC 95. Klijn, JNCI 00. Outcome ...
| PowerPoint PPT presentation | free to download
Progr PowerPoint PPT Presentation
Progr - ... + doxorubicine liposomale p gyl e constitue un moyen th rapeutique suppl mentaire utile dans la prise en charge du cancer des ovaires r cidivant sensible ...
... + doxorubicine liposomale p gyl e constitue un moyen th rapeutique suppl mentaire utile dans la prise en charge du cancer des ovaires r cidivant sensible ...
| PowerPoint PPT presentation | free to download
CSF Guidelines PowerPoint PPT Presentation
CSF Guidelines - American Society of Clinical Oncology 2008 Clinical Practice Guideline Update: Use of Chemotherapy and Radiation Therapy Protectants
American Society of Clinical Oncology 2008 Clinical Practice Guideline Update: Use of Chemotherapy and Radiation Therapy Protectants
| PowerPoint PPT presentation | free to view
Sunitinib vs Capecitabine in Patients with Previously Treated HER2-Negative Advanced Breast Cancer: A Phase III, Randomized, Open-Label Study PowerPoint PPT Presentation
Sunitinib vs Capecitabine in Patients with Previously Treated HER2-Negative Advanced Breast Cancer: A Phase III, Randomized, Open-Label Study - Sunitinib vs Capecitabine in Patients with Previously Treated HER2-Negative Advanced Breast Cancer: A Phase III, Randomized, Open-Label Study
Sunitinib vs Capecitabine in Patients with Previously Treated HER2-Negative Advanced Breast Cancer: A Phase III, Randomized, Open-Label Study
| PowerPoint PPT presentation | free to download
Tubulin Inhibition in Breast Cancer: A Therapeutic Target Critical to Improving Outcomes PowerPoint PPT Presentation
Tubulin Inhibition in Breast Cancer: A Therapeutic Target Critical to Improving Outcomes - Paclitaxel and bevacizumab Capecitabine Capecitabine and docetaxel Gemcitabine and paclitaxel nab-paclitaxel Case #2 (cont.) The patient receives capecitabine as a ...
Paclitaxel and bevacizumab Capecitabine Capecitabine and docetaxel Gemcitabine and paclitaxel nab-paclitaxel Case #2 (cont.) The patient receives capecitabine as a ...
| PowerPoint PPT presentation | free to download
Antitumor antibiotics and PLANT ALKALOIDS PowerPoint PPT Presentation
Antitumor antibiotics and PLANT ALKALOIDS - Antitumor antibiotics and PLANT ALKALOIDS Plant Alkaloids Vinca alkaloids : periwinkle plant (catharanthus rosea) Vincristine, Vinblastine and Vinorelbine
Antitumor antibiotics and PLANT ALKALOIDS Plant Alkaloids Vinca alkaloids : periwinkle plant (catharanthus rosea) Vincristine, Vinblastine and Vinorelbine
| PowerPoint PPT presentation | free to view
Toxicological%20Emergencies%20in%20the%20Oncology%20Patient:%20Antidotal%20Therapies PowerPoint PPT Presentation
Toxicological%20Emergencies%20in%20the%20Oncology%20Patient:%20Antidotal%20Therapies - Toxicological Emergencies in the Oncology Patient: Antidotal Therapies
Toxicological Emergencies in the Oncology Patient: Antidotal Therapies
| PowerPoint PPT presentation | free to download
Role of Novel Microtubule-Targeting Agents in Metastatic Breast Cancer PowerPoint PPT Presentation
Role of Novel Microtubule-Targeting Agents in Metastatic Breast Cancer - Increased Intratumoral Paclitaxel Concentration with nab-paclitaxel Intratumoral paclitaxel Levels following Equal Doses of nab-paclitaxel and Taxol in Nude ...
Increased Intratumoral Paclitaxel Concentration with nab-paclitaxel Intratumoral paclitaxel Levels following Equal Doses of nab-paclitaxel and Taxol in Nude ...
| PowerPoint PPT presentation | free to download
??? MD. PhD. PowerPoint PPT Presentation
??? MD. PhD. - Title: PowerPoint Author: office Last modified by: Alex Yeh Created Date: 6/16/2008 12:47:26 AM Document presentation format:
Title: PowerPoint Author: office Last modified by: Alex Yeh Created Date: 6/16/2008 12:47:26 AM Document presentation format:
| PowerPoint PPT presentation | free to view
2003-2004 Antineoplastics PowerPoint PPT Presentation
2003-2004 Antineoplastics - ... Anastrozole L-asparaginase Azathioprine Bleomycin Busulfan Carmustine (BCNU) Cisplatin Cyclophosphamide Cyclosporine Cyproterone acetate Cytarabine (AraC ...
... Anastrozole L-asparaginase Azathioprine Bleomycin Busulfan Carmustine (BCNU) Cisplatin Cyclophosphamide Cyclosporine Cyproterone acetate Cytarabine (AraC ...
| PowerPoint PPT presentation | free to download
Page of  


PowerPlugs
PowerPlugs
View by Category
Presentations
  • Photo Slideshows
  • Presentations (free-to-view)
    • Concepts & Trends
    • Entertainment
    • Fashion & Beauty
    • Government & Politics
    • How To, Education & Training
    • Medicine, Science & Technology
    • Other
    • Pets & Animals
    • Products & Services
    • Religious & Philosophical
    • Travel & Places
  • Presentations (pay-to-view)
Products Sold on our sister site CrystalGraphics.com
  • Ultimate Combo for PPT
  • PowerPoint Templates
  • Charts & Diagrams for PPT
  • 3D Character Slides
  • Background Videos for PPT
  • More Products for PPT
PowerPlugs
PowerPlugs
CrystalGraphics
Home About Us Terms and Conditions Privacy Policy Contact Us Send Us Feedback
Copyright 2021 CrystalGraphics, Inc. — All rights Reserved. PowerShow.com is a trademark of CrystalGraphics, Inc.
anthracycline — Search results on PowerShow.com
Loading...